Alejandro Dorenbaum

About

Alejandro Dorenbaum, M.D., is a physician executive and academic immunologist best known for senior drug-development roles in biotech and for his Stanford Medicine faculty appointment. SEC filings show he served as Chief Medical Officer of Reneo Pharmaceuticals from January 2018 and previously held CMO roles at Allakos and Lumena Pharmaceuticals. Stanford lists him as a Clinical Professor of Pediatrics - Immunology focused on allergy and immunology.

Areas of interest